Results 1 to 10 of about 33,753 (206)

Current Management of Non-ST-Segment Elevation Acute Coronary Syndrome [PDF]

open access: yesBiomedicines
Cardiovascular disease constitutes the leading cause of morbimortality worldwide. Non-ST-segment elevation acute coronary syndrome (NSTE-ACS) is a common cardiovascular condition, closely related to the ageing population and significantly affecting ...
Pablo Díez-Villanueva   +6 more
doaj   +8 more sources

Pretreatment with Prasugrel in Non–ST-Segment Elevation Acute Coronary Syndromes [PDF]

open access: yesNew England Journal of Medicine, 2013
Although P2Y12 antagonists are effective in patients with non-ST-segment elevation (NSTE) acute coronary syndromes, the effect of the timing of administration--before or after coronary angiography--is not known. We evaluated the effect of administering the P2Y12 antagonist prasugrel at the time of diagnosis versus administering it after the coronary ...
Patrick Goldstein   +2 more
exaly   +6 more sources

Safety of Antiplatelet Pretreatment in Non-ST-segment Elevation Acute Coronary Syndrome. [PDF]

open access: yesEur Cardiol, 2023
Torres-Ruiz G   +4 more
europepmc   +5 more sources

Helicobacter pylori Seropositivity in Patients with Interleukin-1 Polymorphisms Is Significantly Associated with ST-Segment Elevation Myocardial Infarction. [PDF]

open access: yesPLoS ONE, 2016
Helicobacter pylori infection and interleukin-1 polymorphisms are associated with an increased risk of gastric cancer. We examined the prevalence of Helicobacter pylori seropositivity and interleukin-1 polymorphisms between ST-segment elevation ...
Noriaki Tabata   +15 more
doaj   +1 more source

Acute coronary syndrome in patients with prior coronary artery bypass grafting. Literature review

open access: yesРоссийский кардиологический журнал, 2022
Invasive management of patients with ST- segment elevation acute coronary syndrome (ST-ACS) and non-ST-elevation acute coronary syndrome (NSTE-ACS) is a priority and reflected in the current guidelines for management of this category of patients with a ...
O. L. Barbarash   +2 more
doaj   +1 more source

Assessment of apolipoprotein B/apolipoprotein A-I ratio in non-ST segment elevation acute coronary syndrome patients

open access: yesThe Egyptian Heart Journal, 2020
Background The apolipoprotein B/apolipoprotein A-I ratio was shown to be strongly related to the risk of myocardial infarction in several large-scale studies.
Haitham Galal   +2 more
doaj   +1 more source

Use of Thrombus Aspiration for Patients With Acute Coronary Syndrome: Insights From the Nationwide J‐PCI Registry

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background There is significant regional or institutional variation in the use of thrombus aspiration (TA) in patients undergoing percutaneous coronary intervention (PCI).
Taku Inohara   +8 more
doaj   +1 more source

Factor V Leiden Does Not Modify the Phenotype of Acute Coronary Syndrome or the Extent of Myocardial Necrosis

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background The prothrombotic defect factor V Leiden (FVL) may confer higher risk of ST‐segment–elevation myocardial infarction (STEMI), compared with non–ST‐segment–elevation acute coronary syndrome, and may be associated with more myocardial necrosis ...
Bakhtawar K. Mahmoodi   +7 more
doaj   +1 more source

The Potential Role of Cardiac CT in Patients with Acute Coronary Syndrome

open access: yes대한영상의학회지, 2022
Acute coronary syndrome involves three types of coronary artery disease associated with sudden rupture of coronary artery plaque, and has a clinical presentation ranging from ST-segment elevation myocardial infarction (STEMI) to non-ST-segment ...
Sang Hyun Lee, Ki Seok Choo
doaj   +1 more source

Importance of Risk Assessment in Timing of Invasive Coronary Evaluation and Treatment of Patients With Non–ST‐Segment–Elevation Acute Coronary Syndrome: Insights From the VERDICT Trial

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background The optimal timing of invasive examination and treatment of high‐risk patients with non–ST‐segment–elevation acute coronary syndrome has not been established.
Jawad H. Butt   +17 more
doaj   +1 more source

Home - About - Disclaimer - Privacy